China Resources Double-Crane Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 1.18%

China Resources Double-Crane Pharmaceutical Co Ltd (600062) has an Asset Resilience Ratio of 1.18% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Also explore 600062 current and non-current assets for the complete picture of this company's asset base.

Liquid Assets

CN¥200.64 Million

≈ $29.36 Million USD Cash + Short-term Investments

Total Assets

CN¥17.01 Billion

≈ $2.49 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2000–2023)

This chart shows how China Resources Double-Crane Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See 600062 net asset quality score to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down China Resources Double-Crane Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of China Resources Double-Crane Pharmaceuti.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥200.64 Million	1.18%
Total Liquid Assets	CN¥200.64 Million	1.18%

Asset Resilience Insights

Limited Liquidity: China Resources Double-Crane Pharmaceutical Co Ltd maintains only 1.18% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

China Resources Double-Crane Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare China Resources Double-Crane Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Ajanta Pharma Limited NSE:AJANTPHARM	Drug Manufacturers - Specialty & Generic	14.99%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Guizhou Bailing Group Pharmaceutical Co Ltd SHE:002424	Drug Manufacturers - Specialty & Generic	2.09%
Dezhan HealthCare Co Ltd SHE:000813	Drug Manufacturers - Specialty & Generic	0.15%

Annual Asset Resilience Ratio for China Resources Double-Crane Pharmaceutical Co Ltd (2000–2023)

The table below shows the annual Asset Resilience Ratio data for China Resources Double-Crane Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	-0.03%	CN¥-4.88 Million ≈ $-714.09K	CN¥15.43 Billion ≈ $2.26 Billion	-1.42pp
2022-12-31	1.38%	CN¥200.49 Million ≈ $29.34 Million	CN¥14.48 Billion ≈ $2.12 Billion	-4.49pp
2021-12-31	5.88%	CN¥803.58 Million ≈ $117.59 Million	CN¥13.68 Billion ≈ $2.00 Billion	-0.99pp
2020-12-31	6.86%	CN¥851.95 Million ≈ $124.67 Million	CN¥12.42 Billion ≈ $1.82 Billion	+0.14pp
2019-12-31	6.72%	CN¥758.14 Million ≈ $110.94 Million	CN¥11.28 Billion ≈ $1.65 Billion	-1.80pp
2018-12-31	8.53%	CN¥878.68 Million ≈ $128.58 Million	CN¥10.31 Billion ≈ $1.51 Billion	+1.69pp
2017-12-31	6.83%	CN¥644.75 Million ≈ $94.35 Million	CN¥9.44 Billion ≈ $1.38 Billion	+5.01pp
2016-12-31	1.82%	CN¥150.22 Million ≈ $21.98 Million	CN¥8.24 Billion ≈ $1.21 Billion	-3.44pp
2015-12-31	5.26%	CN¥408.65 Million ≈ $59.80 Million	CN¥7.76 Billion ≈ $1.14 Billion	-2.29pp
2014-12-31	7.55%	CN¥500.00 Million ≈ $73.17 Million	CN¥6.62 Billion ≈ $968.61 Million	+7.55pp
2005-12-31	0.00%	CN¥120.00K ≈ $17.56K	CN¥3.81 Billion ≈ $558.00 Million	+0.00pp
2001-12-31	0.00%	CN¥2.60K ≈ $380.46	CN¥2.75 Billion ≈ $401.87 Million	-6.63pp
2000-12-31	6.63%	CN¥98.38 Million ≈ $14.40 Million	CN¥1.48 Billion ≈ $217.18 Million	--

pp = percentage points

About China Resources Double-Crane Pharmaceutical Co Ltd

SHG:600062 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.56 Billion

CN¥17.50 Billion CNY

Market Cap Rank

#5534 Global

#1100 in China

Share Price

CN¥16.85

Change (1 day)

-1.23%

52-Week Range

CN¥16.81 - CN¥21.22

All Time High

CN¥33.06